
Stephen E. Jones
Examiner (ID: 13150, Phone: (571)272-1762 , Office: P/2842 )
| Most Active Art Unit | 2817 |
| Art Unit(s) | 2817, 2843, 2842 |
| Total Applications | 2060 |
| Issued Applications | 1741 |
| Pending Applications | 89 |
| Abandoned Applications | 263 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16899000
[patent_doc_number] => 20210177916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => LONG CHAIN DICARBOXYLIC FATTY ACID (LCDFA) PRODUCING MICROBES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/046903
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30252
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046903
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/046903 | LONG CHAIN DICARBOXYLIC FATTY ACID (LCDFA) PRODUCING MICROBES AND USES THEREOF | Apr 11, 2019 | Abandoned |
Array
(
[id] => 17937088
[patent_doc_number] => 11471520
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Enhanced
[patent_app_type] => utility
[patent_app_number] => 17/042671
[patent_app_country] => US
[patent_app_date] => 2019-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14463
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17042671
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/042671 | Enhanced | Apr 2, 2019 | Issued |
Array
(
[id] => 14576967
[patent_doc_number] => 20190216092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => USE OF PROTEINS TO CONTROL MOLLUSCS
[patent_app_type] => utility
[patent_app_number] => 16/367880
[patent_app_country] => US
[patent_app_date] => 2019-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7253
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16367880
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/367880 | Use of proteins to control molluscs | Mar 27, 2019 | Issued |
Array
(
[id] => 17648505
[patent_doc_number] => 11351208
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Altering the intestinal microbiome in cystic fibrosis
[patent_app_type] => utility
[patent_app_number] => 16/979824
[patent_app_country] => US
[patent_app_date] => 2019-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 28
[patent_no_of_words] => 18641
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16979824
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/979824 | Altering the intestinal microbiome in cystic fibrosis | Mar 25, 2019 | Issued |
Array
(
[id] => 18012134
[patent_doc_number] => 11504408
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Fasting-mimicking diet (FMD) but not water-only fasting promotes reversal of inflammation and IBD pathology
[patent_app_type] => utility
[patent_app_number] => 16/976952
[patent_app_country] => US
[patent_app_date] => 2019-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 27
[patent_no_of_words] => 13712
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16976952
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/976952 | Fasting-mimicking diet (FMD) but not water-only fasting promotes reversal of inflammation and IBD pathology | Mar 14, 2019 | Issued |
Array
(
[id] => 16596614
[patent_doc_number] => 20210023145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => Probiotic Composition and Feed Additive
[patent_app_type] => utility
[patent_app_number] => 16/980713
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10669
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980713
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/980713 | Probiotic composition and feed additive | Mar 13, 2019 | Issued |
Array
(
[id] => 17741443
[patent_doc_number] => 11389488
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Stool collection method and sample preparation method for transplanting fecal microbiota
[patent_app_type] => utility
[patent_app_number] => 16/979077
[patent_app_country] => US
[patent_app_date] => 2019-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 12997
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16979077
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/979077 | Stool collection method and sample preparation method for transplanting fecal microbiota | Mar 7, 2019 | Issued |
Array
(
[id] => 15023409
[patent_doc_number] => 20190322709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => Tuberculosis Compositions And Methods Of Using The Same
[patent_app_type] => utility
[patent_app_number] => 16/289919
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20198
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16289919
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/289919 | Tuberculosis compositions and methods of using the same | Feb 28, 2019 | Issued |
Array
(
[id] => 16539366
[patent_doc_number] => 20200405779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => BACTERIAL BIOFILMS AND CANCER
[patent_app_type] => utility
[patent_app_number] => 16/976721
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21320
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16976721
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/976721 | Bacterial biofilms and cancer | Feb 27, 2019 | Issued |
Array
(
[id] => 17312857
[patent_doc_number] => 20210401905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => COMBINATION OF LACTOBACILLI FOR THE RELIEF OF IRRITABLE BOWEL SYNDROME AND FOR THE RELIEF OF OTHER GASTROINTESTINAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/978575
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8603
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16978575
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/978575 | COMBINATION OF LACTOBACILLI FOR THE RELIEF OF IRRITABLE BOWEL SYNDROME AND FOR THE RELIEF OF OTHER GASTROINTESTINAL DISORDERS | Feb 27, 2019 | Abandoned |
Array
(
[id] => 14583971
[patent_doc_number] => 20190219594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => PREDICTIVE BIOMARKERS OF CLINICAL RESPONSE TO ANTI-LPS IMMUNOGLOBULIN TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/282389
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11212
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16282389
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/282389 | PREDICTIVE BIOMARKERS OF CLINICAL RESPONSE TO ANTI-LPS IMMUNOGLOBULIN TREATMENT | Feb 21, 2019 | Abandoned |
Array
(
[id] => 16748842
[patent_doc_number] => 20210100851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => BACILLUS BACTERIUM, INTERLEUKIN-22 PRODUCTION INDUCING AGENT, SKIN BARRIER FUNCTION ENHANCING AGENT
[patent_app_type] => utility
[patent_app_number] => 16/970018
[patent_app_country] => US
[patent_app_date] => 2019-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970018
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/970018 | BACILLUS BACTERIUM, INTERLEUKIN-22 PRODUCTION INDUCING AGENT, SKIN BARRIER FUNCTION ENHANCING AGENT | Feb 14, 2019 | Abandoned |
Array
(
[id] => 14338913
[patent_doc_number] => 20190151429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF TUBERCULOSIS
[patent_app_type] => utility
[patent_app_number] => 16/266224
[patent_app_country] => US
[patent_app_date] => 2019-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41106
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16266224
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/266224 | Compositions and methods for the treatment or prevention of tuberculosis | Feb 3, 2019 | Issued |
Array
(
[id] => 16656039
[patent_doc_number] => 20210052675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => NANOVESICLES DERIVED FROM BACTERIA OF LACTOCOCCUS GENUS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/968058
[patent_app_country] => US
[patent_app_date] => 2019-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8582
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968058
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968058 | Nanovesicles derived from bacteria of | Jan 31, 2019 | Issued |
Array
(
[id] => 16656033
[patent_doc_number] => 20210052669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING IMMUNE DISORDERS USING LACHNOSPIRACEAE BACTERIA
[patent_app_type] => utility
[patent_app_number] => 16/965836
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16965836
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/965836 | COMPOSITIONS AND METHODS FOR TREATING IMMUNE DISORDERS USING LACHNOSPIRACEAE BACTERIA | Jan 30, 2019 | Abandoned |
Array
(
[id] => 14622251
[patent_doc_number] => 20190224493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => SYSTEMS, METHODS AND COMPOSITIONS FOR OPTICAL STIMULATION OF TARGET CELLS
[patent_app_type] => utility
[patent_app_number] => 16/261388
[patent_app_country] => US
[patent_app_date] => 2019-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16261388
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/261388 | SYSTEMS, METHODS AND COMPOSITIONS FOR OPTICAL STIMULATION OF TARGET CELLS | Jan 28, 2019 | Abandoned |
Array
(
[id] => 17569938
[patent_doc_number] => 11318192
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-03
[patent_title] => Engineered proteins and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/963920
[patent_app_country] => US
[patent_app_date] => 2019-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 31
[patent_no_of_words] => 29390
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16963920
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/963920 | Engineered proteins and methods of use | Jan 24, 2019 | Issued |
Array
(
[id] => 16657397
[patent_doc_number] => 20210054033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => METHODS AND COMPOSITIONS FOR USE OF RECOMBINANT BACTERIAL EFFECTOR PROTEINS AS ANTI-INFLAMMATORY AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/964762
[patent_app_country] => US
[patent_app_date] => 2019-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25165
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16964762
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/964762 | METHODS AND COMPOSITIONS FOR USE OF RECOMBINANT BACTERIAL EFFECTOR PROTEINS AS ANTI-INFLAMMATORY AGENTS | Jan 24, 2019 | Abandoned |
Array
(
[id] => 17814313
[patent_doc_number] => 11419901
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 16/964577
[patent_app_country] => US
[patent_app_date] => 2019-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 44
[patent_no_of_words] => 18287
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16964577
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/964577 | None | Jan 22, 2019 | Issued |
Array
(
[id] => 16415842
[patent_doc_number] => 10823725
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-03
[patent_title] => Cell-based method for determining an activity of botulinum toxin
[patent_app_type] => utility
[patent_app_number] => 16/245415
[patent_app_country] => US
[patent_app_date] => 2019-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 59
[patent_no_of_words] => 27316
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16245415
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/245415 | Cell-based method for determining an activity of botulinum toxin | Jan 10, 2019 | Issued |